FR2525602B1 - - Google Patents

Info

Publication number
FR2525602B1
FR2525602B1 FR8206841A FR8206841A FR2525602B1 FR 2525602 B1 FR2525602 B1 FR 2525602B1 FR 8206841 A FR8206841 A FR 8206841A FR 8206841 A FR8206841 A FR 8206841A FR 2525602 B1 FR2525602 B1 FR 2525602B1
Authority
FR
France
Prior art keywords
radical
alkyl
optionally carrying
hydrogen atom
halogen atom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8206841A
Other languages
English (en)
French (fr)
Other versions
FR2525602A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo SA filed Critical Synthelabo SA
Priority to FR8206841A priority Critical patent/FR2525602A1/fr
Priority to EP83400706A priority patent/EP0092459B1/fr
Priority to AT83400706T priority patent/ATE23860T1/de
Priority to DE8383400706T priority patent/DE3367918D1/de
Priority to US06/484,611 priority patent/US4492695A/en
Priority to HU831381A priority patent/HU189648B/hu
Priority to ES521651A priority patent/ES521651A0/es
Priority to ZA832787A priority patent/ZA832787B/xx
Priority to NZ203955A priority patent/NZ203955A/en
Priority to PT76574A priority patent/PT76574B/pt
Priority to FI831349A priority patent/FI73998C/fi
Priority to DK173783A priority patent/DK173783A/da
Priority to NO831390A priority patent/NO156048C/no
Priority to AU13700/83A priority patent/AU553112B2/en
Priority to GR71139A priority patent/GR78577B/el
Priority to IL68443A priority patent/IL68443A0/xx
Priority to JP58070849A priority patent/JPS58189180A/ja
Priority to IE896/83A priority patent/IE54923B1/en
Priority to CA000426243A priority patent/CA1254207A/en
Publication of FR2525602A1 publication Critical patent/FR2525602A1/fr
Application granted granted Critical
Publication of FR2525602B1 publication Critical patent/FR2525602B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pyridine Compounds (AREA)
FR8206841A 1982-04-21 1982-04-21 Imidazo(1,2-a)pyridines, leur preparation et leur application en therapeutique Granted FR2525602A1 (fr)

Priority Applications (19)

Application Number Priority Date Filing Date Title
FR8206841A FR2525602A1 (fr) 1982-04-21 1982-04-21 Imidazo(1,2-a)pyridines, leur preparation et leur application en therapeutique
EP83400706A EP0092459B1 (fr) 1982-04-21 1983-04-07 Imidazo(1,2-a)pyridines, leur préparation et leur application en thérapeutique
AT83400706T ATE23860T1 (de) 1982-04-21 1983-04-07 Imidazo(1,2-a)pyridine, ihre herstellung und therapeutische verwendung.
DE8383400706T DE3367918D1 (en) 1982-04-21 1983-04-07 Imidazo(1,2-a)pyridines, their preparation and therapeutical use
US06/484,611 US4492695A (en) 1982-04-21 1983-04-13 Therapeutically useful imidazo[1,2-a]pyridine derivatives
GR71139A GR78577B (cg-RX-API-DMAC10.html) 1982-04-21 1983-04-20
ZA832787A ZA832787B (en) 1982-04-21 1983-04-20 Therapeutically useful imidazo (1,2-a)pyridine derivatives
NZ203955A NZ203955A (en) 1982-04-21 1983-04-20 Imidazo(1,2,-a)pyridine derivatives and pharmaceutical compositions
PT76574A PT76574B (fr) 1982-04-21 1983-04-20 Procede de preparation de derives d'imidazo <1,2-a> pyridine et de compositions pharmaceutiques les contenant
FI831349A FI73998C (fi) 1982-04-21 1983-04-20 Saett att framstaella terapeutiskt anvaendbara imidazo/1,2- /pyridiner.
HU831381A HU189648B (en) 1982-04-21 1983-04-20 Process for producing imidazo/1,2-a/pyridine derivatives and pharmaceutical compositions containing them
NO831390A NO156048C (no) 1982-04-21 1983-04-20 Analogifremgangsmaate for fremstilling av farmasoeytisk aktive imidazopyridinderivater
AU13700/83A AU553112B2 (en) 1982-04-21 1983-04-20 Imidazo(1,2-alpha) pyridine derivatives
ES521651A ES521651A0 (es) 1982-04-21 1983-04-20 Un procedimiento de preparacion de imidazo(1,2-x)piridinas.
IL68443A IL68443A0 (en) 1982-04-21 1983-04-20 Imidazo(1,2-)pyridine derivatives,their preparation and pharmaceutical compositions containing them
JP58070849A JPS58189180A (ja) 1982-04-21 1983-04-20 イミダゾピリジン化合物およびその医薬への応用
IE896/83A IE54923B1 (en) 1982-04-21 1983-04-20 Therapeutically useful imidazo (1,2-a) pyridine derivatives
CA000426243A CA1254207A (en) 1982-04-21 1983-04-20 THERAPEUTICALLY USEFUL IMIDAZO¬1,2-.alpha.|PYRIDINE DERIVATIVES
DK173783A DK173783A (da) 1982-04-21 1983-04-20 Fremgangsmaade til fremstilling af imidazo (1,2-alfa)pyridiner

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8206841A FR2525602A1 (fr) 1982-04-21 1982-04-21 Imidazo(1,2-a)pyridines, leur preparation et leur application en therapeutique

Publications (2)

Publication Number Publication Date
FR2525602A1 FR2525602A1 (fr) 1983-10-28
FR2525602B1 true FR2525602B1 (cg-RX-API-DMAC10.html) 1984-06-22

Family

ID=9273216

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8206841A Granted FR2525602A1 (fr) 1982-04-21 1982-04-21 Imidazo(1,2-a)pyridines, leur preparation et leur application en therapeutique

Country Status (19)

Country Link
US (1) US4492695A (cg-RX-API-DMAC10.html)
EP (1) EP0092459B1 (cg-RX-API-DMAC10.html)
JP (1) JPS58189180A (cg-RX-API-DMAC10.html)
AT (1) ATE23860T1 (cg-RX-API-DMAC10.html)
AU (1) AU553112B2 (cg-RX-API-DMAC10.html)
CA (1) CA1254207A (cg-RX-API-DMAC10.html)
DE (1) DE3367918D1 (cg-RX-API-DMAC10.html)
DK (1) DK173783A (cg-RX-API-DMAC10.html)
ES (1) ES521651A0 (cg-RX-API-DMAC10.html)
FI (1) FI73998C (cg-RX-API-DMAC10.html)
FR (1) FR2525602A1 (cg-RX-API-DMAC10.html)
GR (1) GR78577B (cg-RX-API-DMAC10.html)
HU (1) HU189648B (cg-RX-API-DMAC10.html)
IE (1) IE54923B1 (cg-RX-API-DMAC10.html)
IL (1) IL68443A0 (cg-RX-API-DMAC10.html)
NO (1) NO156048C (cg-RX-API-DMAC10.html)
NZ (1) NZ203955A (cg-RX-API-DMAC10.html)
PT (1) PT76574B (cg-RX-API-DMAC10.html)
ZA (1) ZA832787B (cg-RX-API-DMAC10.html)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3406329A1 (de) * 1984-02-22 1985-08-22 Merck Patent Gmbh, 6100 Darmstadt Pyridone
FR2606410B1 (fr) * 1986-11-07 1989-02-24 Synthelabo Imidazopyridines, leur preparation et leur application en therapeutique
US5364849A (en) * 1989-04-22 1994-11-15 John Wyeth & Brother, Limited 1-[3 or 4-[1-[4-piperazinyl]]-2 arylpropionyl or butryl]-heterocyclic derivatives
WO1995001980A1 (en) * 1993-07-06 1995-01-19 Pfizer Inc. Bicyclic tetrahydro pyrazolopyridines
WO1998025926A1 (en) * 1996-12-11 1998-06-18 Takeda Chemical Industries, Ltd. Imidazopyridine derivatives and their production
AUPP278498A0 (en) 1998-04-03 1998-04-30 Australian Nuclear Science & Technology Organisation Peripheral benzodiazepine receptor binding agents
DK1219621T3 (da) 1999-07-30 2004-02-02 Zenyaku Kogyo Kk Azaindolizinonderivater og cerebral funktionsforbedrende midler indeholdende disse som den aktive bestanddel
IT1318624B1 (it) 2000-07-14 2003-08-27 Dinamite Dipharma S P A In For Processo per la preparazione di 2-fenil-imidazo (1,2-a)piridin-3-acetammidi.
SE0003186D0 (sv) * 2000-09-07 2000-09-07 Astrazeneca Ab New process
US6596731B2 (en) 2001-03-27 2003-07-22 Hoffmann-La Roche Inc. Substituted imidazo[1,2-A] pyridine derivatives
US8555875B2 (en) 2008-12-23 2013-10-15 Map Pharmaceuticals, Inc. Inhalation devices and related methods for administration of sedative hypnotic compounds
WO2010117787A2 (en) * 2009-03-30 2010-10-14 The Brigham And Women's Hospital, Inc. Inhibiting eph b-3 kinase
BR112012010752B1 (pt) 2009-11-05 2021-07-20 University Of Notre Dame Du Lac Compostos imidazo[1,2-a]piridina
CN103360387B (zh) * 2012-03-28 2016-12-14 江苏豪森药业集团有限公司 一种制备化合物唑吡坦的方法
WO2017049321A1 (en) 2015-09-17 2017-03-23 Miller Marvin J Benzyl amine-containing heterocyclic compounds and compositions useful against mycobacterial infection
EP3468545A4 (en) 2016-06-08 2020-07-22 President and Fellows of Harvard College METHODS AND COMPOSITIONS FOR REDUCING TACTILE DYSFUNCTION AND ANXIETY ASSOCIATED WITH AUTISM SPECTRUM DISORDER, RETT SYNDROME AND FRAGILE X SYNDROME
CN107163039A (zh) * 2017-05-11 2017-09-15 浙江工业大学 一种6‑甲基‑2‑对甲苯基咪唑并[1,2‑a]吡啶‑3‑甲醛的制备方法
EP3797097A4 (en) 2018-05-22 2022-03-09 President and Fellows of Harvard College Compositions and methods for reducing tactile dysfunction, anxiety, and social impairment
US11434244B2 (en) 2018-05-29 2022-09-06 President And Fellows Of Harvard College Compositions and methods for reducing tactile dysfunction, anxiety, and social impairment
EP3946390A4 (en) 2019-03-25 2022-12-21 President and Fellows of Harvard College COMPOSITIONS AND METHODS TO REDUCE TACTILE DYSFUNCTION, ANXIETY AND SOCIAL DISABILITIES

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1076089A (en) * 1965-11-09 1967-07-19 Selvi & C Lab Bioterapico New derivatives of imidazo [1,2-a]-pyridine and a process for the manufacture thereof
FR2492382A1 (fr) * 1980-10-22 1982-04-23 Synthelabo Derives d'imidazo (1,2-a) pyridine, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
IL68443A0 (en) 1983-07-31
GR78577B (cg-RX-API-DMAC10.html) 1984-09-27
JPS58189180A (ja) 1983-11-04
IE830896L (en) 1983-10-21
EP0092459A2 (fr) 1983-10-26
ZA832787B (en) 1983-12-28
JPH0412270B2 (cg-RX-API-DMAC10.html) 1992-03-04
NO156048B (no) 1987-04-06
ES8402298A1 (es) 1984-01-16
PT76574B (fr) 1986-02-27
EP0092459A3 (en) 1984-02-01
FI831349L (fi) 1983-10-22
PT76574A (fr) 1983-05-01
ATE23860T1 (de) 1986-12-15
NO831390L (no) 1983-10-24
NZ203955A (en) 1985-11-08
US4492695A (en) 1985-01-08
AU553112B2 (en) 1986-07-03
NO156048C (no) 1987-07-15
FI73998B (fi) 1987-08-31
CA1254207A (en) 1989-05-16
DK173783D0 (da) 1983-04-20
EP0092459B1 (fr) 1986-11-26
HU189648B (en) 1986-07-28
ES521651A0 (es) 1984-01-16
DK173783A (da) 1983-10-22
FR2525602A1 (fr) 1983-10-28
FI73998C (fi) 1987-12-10
IE54923B1 (en) 1990-03-28
AU1370083A (en) 1983-10-27
DE3367918D1 (en) 1987-01-15
FI831349A0 (fi) 1983-04-20

Similar Documents

Publication Publication Date Title
FR2525602B1 (cg-RX-API-DMAC10.html)
ES8207537A1 (es) Procedimiento de preparacion de imidazo (1,2-a)piridinas
UA41290C2 (uk) Гетероариламіни, фармацевтична композиція, спосіб інгібування холінестерази у ссавців, спосіб покращення пам&#39;яті
GR3002051T3 (en) 3-oxadiazolyl and 3-carboxylic-acid beta-carboline derivatives, their preparation and their use as medicaments
AU554959B2 (en) Triazolo(4,3-a) quinazolin-5-ones
DE3161553D1 (en) Thiazolo(3,2-a)pyrimidine derivatives, their preparation and pharmaceutical compositions containing them
GR76063B (cg-RX-API-DMAC10.html)
NZ196754A (en) 2-benzyl-3-phenyl-(2,3,5,6-tetrahydroimidazo-(2,1-6) thiazol- or 2,3,6,7-tetrahydro-5h-thiazolo (3,2-a)-pyrimid)-3-ols
IL82419A (en) 3-amino-dihydropyridines,their preparation and medicaments containing them